189 related articles for article (PubMed ID: 28826422)
1. A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data.
Bollaerts K; Riera-Montes M; Heininger U; Hens N; Souverain A; Verstraeten T; Hartwig S
Epidemiol Infect; 2017 Oct; 145(13):2666-2677. PubMed ID: 28826422
[TBL] [Abstract][Full Text] [Related]
2. Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization.
Riera-Montes M; Bollaerts K; Heininger U; Hens N; Gabutti G; Gil A; Nozad B; Mirinaviciute G; Flem E; Souverain A; Verstraeten T; Hartwig S
BMC Infect Dis; 2017 May; 17(1):353. PubMed ID: 28521810
[TBL] [Abstract][Full Text] [Related]
3. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of varicella-zoster virus in Polish population.
Siennicka J; Trzcińska A; Rosińska M; Litwińska B
Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
[TBL] [Abstract][Full Text] [Related]
5. Burden of varicella in Latin America and the Caribbean: findings from a systematic literature review.
Arlant LHF; Garcia MCP; Avila Aguero ML; Cashat M; Parellada CI; Wolfson LJ
BMC Public Health; 2019 May; 19(1):528. PubMed ID: 31068173
[TBL] [Abstract][Full Text] [Related]
6. Burden of varicella in Central and Eastern Europe: findings from a systematic literature review.
Mészner Z; Wysocki J; Richter D; Zavadska D; Ivaskeviciene I; Usonis V; Pokorn M; Mangarov A; Jancoriene L; Man SC; Kristufkova Z; Jesenak M; Tešović G; Pluta J; Wolfson LJ
Expert Rev Vaccines; 2019 Mar; 18(3):281-293. PubMed ID: 30810402
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
[TBL] [Abstract][Full Text] [Related]
8. Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccines.
Cohen DI; Davidovici BB; Smetana Z; Balicer RD; Klement E; Mendelson E; Green MS
Infection; 2006 Aug; 34(4):208-13. PubMed ID: 16896579
[TBL] [Abstract][Full Text] [Related]
9. Projections of zoster incidence in Australia based on demographic and transmission models of varicella-zoster virus infection.
Costantino V; Gidding HF; Wood JG
Vaccine; 2017 Dec; 35(48 Pt B):6737-6742. PubMed ID: 29050801
[TBL] [Abstract][Full Text] [Related]
10. Varicella-zoster virus: pathogenesis, incidence patterns and vaccination programs.
Gabutti G; Franchi M; Maniscalco L; Stefanati A
Minerva Pediatr; 2016 Jun; 68(3):213-25. PubMed ID: 27125440
[TBL] [Abstract][Full Text] [Related]
11. Varicella zoster virus vaccination policies and surveillance strategies in Europe.
Pinot de Moira A; Nardone A;
Euro Surveill; 2005 Jan; 10(1):43-5. PubMed ID: 15701939
[TBL] [Abstract][Full Text] [Related]
12. A seroepidemiology study of varicella among children aged 0-12 years in Taiwan.
Tseng HF; Tan HF; Chang CK; Wang LY; Yang SE; Liau MY; Pan MJ; Chen CY; Huang SP
Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1201-7. PubMed ID: 16438146
[TBL] [Abstract][Full Text] [Related]
13. Varicella in Europe-A review of the epidemiology and experience with vaccination.
Helmuth IG; Poulsen A; Suppli CH; Mølbak K
Vaccine; 2015 May; 33(21):2406-13. PubMed ID: 25839105
[TBL] [Abstract][Full Text] [Related]
14. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.
Wood SM; Shah SS; Steenhoff AP; Rutstein RM
Pediatrics; 2008 Jan; 121(1):e150-6. PubMed ID: 18086820
[TBL] [Abstract][Full Text] [Related]
15. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region.
Nardone A; de Ory F; Carton M; Cohen D; van Damme P; Davidkin I; Rota MC; de Melker H; Mossong J; Slacikova M; Tischer A; Andrews N; Berbers G; Gabutti G; Gay N; Jones L; Jokinen S; Kafatos G; de Aragón MV; Schneider F; Smetana Z; Vargova B; Vranckx R; Miller E
Vaccine; 2007 Nov; 25(45):7866-72. PubMed ID: 17919788
[TBL] [Abstract][Full Text] [Related]
16. Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey.
Alp H; Altinkaynak S; Ertekin V; Kiliçaslan B; Giiraksin A
Health Policy; 2005 Apr; 72(1):119-24. PubMed ID: 15760704
[TBL] [Abstract][Full Text] [Related]
17. Incidence and use of resources for chickenpox and herpes zoster in Latin America and the Caribbean--a systematic review and meta-analysis.
Bardach A; Cafferata ML; Klein K; Cormick G; Gibbons L; Ruvinsky S
Pediatr Infect Dis J; 2012 Dec; 31(12):1263-8. PubMed ID: 23188098
[TBL] [Abstract][Full Text] [Related]
18. The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium).
Thiry N; Beutels P; Shkedy Z; Vranckx R; Vandermeulen C; Wielen MV; Damme PV
Eur J Pediatr; 2002 Nov; 161(11):588-93. PubMed ID: 12424583
[TBL] [Abstract][Full Text] [Related]
19. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
[TBL] [Abstract][Full Text] [Related]
20. Seroepidemiology of varicella-zoster in Pakistan.
Akram DS; Qureshi H; Mahmud A; Khan AA; Kundi Z; Shafi S; N-ur-Rehman ; Olowokure B; Weil J; Bock H; Yazdani I
Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):646-9. PubMed ID: 11414405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
